US says Tamiflu for the sick, not a preventive

Sep 08, 2009 By MIKE STOBBE , AP Medical Writer

(AP) -- Federal health officials put out new guidelines Tuesday that say the flu medicines Tamiflu and Relenza should only be used to treat people who are sick with the flu and at high risk for complications.

The new advice tries to close a door that government doctors had left open in May. Back then, they didn't rule out sometimes using the drugs to stop swine flu's spread and prevent illness even in children who had no symptoms.

Now that swine is so common, health officials say the medicines should be reserved for people at higher risk of complications.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: FDA approves second vaccine against meningitis strain

add to favorites email to friend print save as pdf

Related Stories

Flu drug advised for pregnant women with swine flu

May 12, 2009

(AP) -- Pregnant women should take prescription flu medicines if they are diagnosed with the new swine flu, health officials said Tuesday. So far, the swine flu has not proven to be much more dangerous than seasonal influenza, ...

Mexico City closes museums to stop flu outbreak

Apr 24, 2009

(AP) -- Mexico's federal government has closed museums, libraries, and state-run theaters as well as schools in its overcrowded capital to stop a swine flu outbreak authorities say may have killed as many ...

Recommended for you

Medical charity warns India over patent rules

Jan 21, 2015

Doctors without Borders on Wednesday warned the Indian government not to bow to US pressure to amend patent regulations that allow millions access to affordable medicines, ahead of a visit by President Barack Obama.

Why are some generic drugs getting so expensive?

Jan 21, 2015

More than eight out of every 10 prescriptions dispensed in the US is generic. This growth is due to a large number of top-selling drugs going off patent over the past decade, as well as innovations in t ...

Supreme Court sides with Teva in drug dispute

Jan 20, 2015

The Supreme Court on Tuesday sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.